OCT Human Kidney Dataset for PRB Guidance

The dataset for the paper "Automatic renal carcinoma biopsy guidance using forward-viewing endoscopic optical coherence tomography and deep learning". The study was approved by the University of Oklahoma Institutional Review Board (Study number: 12462). Written informed consent was obtained by Lifeshare of Oklahoma. Patient demographics were collected upon obtaining consent. For our dataset, we utilized nine human kidney samples with renal carcinoma. OCT images of carcinoma tissue and different normal tissues were imaged by our OCT probe. Furthermore, to compare benign renal tumor against malignant renal carcinoma in this study, we conducted OCT imaging on one kidney sample with oncocytoma, which is a well-defined benign solid tumor arising from proximal renal tubule. To keep the organ as fresh as possible, all the kidney samples were preserved by hypothermic machine perfusion (HMP), and we started the experiment as soon as the sample was acquired. 

Currently we uploaded one of the ten kidneys due to the size of the data, more kidneys will be updated in the future.

本数据集对应论文《基于前视内镜光学相干断层扫描与深度学习的肾癌活检引导自动化》。本研究经俄克拉荷马大学伦理审查委员会批准（研究编号：12462），书面知情同意由俄克拉荷马生命共享组织（Lifeshare of Oklahoma）获取。知情同意获取后，收集了患者的人口统计学特征资料。

本数据集共纳入9例携带肾癌的人体肾脏样本，使用本研究的光学相干断层扫描（optical coherence tomography, OCT）探头对癌组织及不同类型正常组织进行OCT成像。此外，为开展肾良性肿瘤与恶性肾癌的对照研究，我们还对1例伴嗜酸性细胞瘤（oncocytoma）的肾脏样本进行了OCT成像；嗜酸性细胞瘤是一种起源于近端肾小管的明确良性实体瘤。为尽可能维持肾脏组织的新鲜度，所有肾脏样本均采用低温机器灌注（hypothermic machine perfusion, HMP）进行保存，并在样本获取后立即启动实验。

受数据量限制，目前仅上传了10例肾脏样本中的1例，后续将更新更多样本数据。